Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis.
(2020) Critical Care — Vol. 24, n° 1, p. 410 [1-3] (2020)
Files
2020_Verroken_Crit_Care.pdf
Open Access - Adobe PDF
- 450.36 KB
Details
- Authors
- Abstract
- International guidelines recommend the initiation of empirical antibiotherapy for possible associated bacterial pneumonia in COVID-19 critically ill yet further suggesting a rapid reassessment upon source documentation [1]. In this prospective cohort analysis, we investigated the respiratory co-infection rate in COVID-19 critically ill through the use of rapid molecular testing and measured its impact on antibiotic management. [...]
- Affiliations
Citations
Verroken, A., Scohy, A., Gérard, L., Wittebole, X., Collienne, C., & Laterre, P.-F. (2020). Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis. Critical Care, 24(1), 410 [1-3]. https://doi.org/10.1186/s13054-020-03135-7 (Original work published 2020)